169 related articles for article (PubMed ID: 35229965)
1. Targeting neonatal Fc receptor: potential clinical applications in pregnancy.
Moise KJ; Oepkes D; Lopriore E; Bredius RGM
Ultrasound Obstet Gynecol; 2022 Aug; 60(2):167-175. PubMed ID: 35229965
[TBL] [Abstract][Full Text] [Related]
2. Expression of the neonatal Fc-receptor in placental-fetal endothelium and in cells of the placental immune system.
Kiskova T; Mytsko Y; Schepelmann M; Helmer H; Fuchs R; Miedl H; Wadsack C; Ellinger I
Placenta; 2019 Mar; 78():36-43. PubMed ID: 30955709
[TBL] [Abstract][Full Text] [Related]
3. M281, an anti-FcRn antibody, inhibits IgG transfer in a human ex vivo placental perfusion model.
Roy S; Nanovskaya T; Patrikeeva S; Cochran E; Parge V; Guess J; Schaeck J; Choudhury A; Ahmed M; Ling LE
Am J Obstet Gynecol; 2019 May; 220(5):498.e1-498.e9. PubMed ID: 30849355
[TBL] [Abstract][Full Text] [Related]
4. Certolizumab pegol does not bind the neonatal Fc receptor (FcRn): Consequences for FcRn-mediated in vitro transcytosis and ex vivo human placental transfer.
Porter C; Armstrong-Fisher S; Kopotsha T; Smith B; Baker T; Kevorkian L; Nesbitt A
J Reprod Immunol; 2016 Aug; 116():7-12. PubMed ID: 27123565
[TBL] [Abstract][Full Text] [Related]
5. The therapeutic age of the neonatal Fc receptor.
Pyzik M; Kozicky LK; Gandhi AK; Blumberg RS
Nat Rev Immunol; 2023 Jul; 23(7):415-432. PubMed ID: 36726033
[TBL] [Abstract][Full Text] [Related]
6. Human IgG lacking effector functions demonstrate lower FcRn-binding and reduced transplacental transport.
Stapleton NM; Armstrong-Fisher SS; Andersen JT; van der Schoot CE; Porter C; Page KR; Falconer D; de Haas M; Williamson LM; Clark MR; Vidarsson G; Armour KL
Mol Immunol; 2018 Mar; 95():1-9. PubMed ID: 29367080
[TBL] [Abstract][Full Text] [Related]
7. Expression of FcRn receptor in placental tissue and its relationship with IgG levels in term and preterm newborns.
Lozano NA; Lozano A; Marini V; Saranz RJ; Blumberg RS; Baker K; Agresta MF; Ponzio MF
Am J Reprod Immunol; 2018 Sep; 80(3):e12972. PubMed ID: 29745444
[TBL] [Abstract][Full Text] [Related]
8. FcRn, but not FcγRs, drives maternal-fetal transplacental transport of human IgG antibodies.
Borghi S; Bournazos S; Thulin NK; Li C; Gajewski A; Sherwood RW; Zhang S; Harris E; Jagannathan P; Wang LX; Ravetch JV; Wang TT
Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12943-12951. PubMed ID: 32461366
[TBL] [Abstract][Full Text] [Related]
9. Implications of Fc Neonatal Receptor (FcRn) Manipulations for Transplant Immunotherapeutics.
Jordan SC; Ammerman N; Vo A
Transplantation; 2020 Jan; 104(1):17-23. PubMed ID: 31397806
[TBL] [Abstract][Full Text] [Related]
10. Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal Fc receptor in the pathogenesis and therapy.
Chen P; Li C; Lang S; Zhu G; Reheman A; Spring CM; Freedman J; Ni H
Blood; 2010 Nov; 116(18):3660-8. PubMed ID: 20647570
[TBL] [Abstract][Full Text] [Related]
11. Evidence that FcRn mediates the transplacental passage of maternal IgE in the form of IgG anti-IgE/IgE immune complexes.
Bundhoo A; Paveglio S; Rafti E; Dhongade A; Blumberg RS; Matson AP
Clin Exp Allergy; 2015 Jun; 45(6):1085-98. PubMed ID: 25652137
[TBL] [Abstract][Full Text] [Related]
12. The Neonatal Fc Receptor (FcRn): A Misnomer?
Pyzik M; Sand KMK; Hubbard JJ; Andersen JT; Sandlie I; Blumberg RS
Front Immunol; 2019; 10():1540. PubMed ID: 31354709
[TBL] [Abstract][Full Text] [Related]
13. Neonatal Fc receptor in human immunity: Function and role in therapeutic intervention.
Patel DD; Bussel JB
J Allergy Clin Immunol; 2020 Sep; 146(3):467-478. PubMed ID: 32896307
[TBL] [Abstract][Full Text] [Related]
14. The neonatal Fc receptor: Key to homeostasic control of IgG and IgG-related biopharmaceuticals.
Baldwin WM; Valujskikh A; Fairchild RL
Am J Transplant; 2019 Jul; 19(7):1881-1887. PubMed ID: 30903736
[TBL] [Abstract][Full Text] [Related]
15. Human IgE does not bind to human FcRn.
Brinkhaus M; van der Kooi EJ; Bentlage AEH; Ooijevaar-de Heer P; Derksen NIL; Rispens T; Vidarsson G
Sci Rep; 2022 Jan; 12(1):62. PubMed ID: 34996950
[TBL] [Abstract][Full Text] [Related]
16. Maternofetal transplacental transport of recombinant IgG antibodies lacking effector functions.
Mathiesen L; Nielsen LK; Andersen JT; Grevys A; Sandlie I; Michaelsen TE; Hedegaard M; Knudsen LE; Dziegiel MH
Blood; 2013 Aug; 122(7):1174-81. PubMed ID: 23843496
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the Role of a Second Fc-Binding Receptor in Placental IgG Transfer in Nonhuman Primates.
Rosenberg YJ; Ordonez T; Khanwalkar US; Barnette P; Pandey S; Backes IM; Otero CE; Goldberg BS; Crowley AR; Leib DA; Shapiro MB; Jiang X; Urban LA; Lees J; Hessell AJ; Permar S; Haigwood NL; Ackerman ME
mBio; 2023 Apr; 14(2):e0034123. PubMed ID: 36946726
[TBL] [Abstract][Full Text] [Related]
18. Associations between an IgG3 polymorphism in the binding domain for FcRn, transplacental transfer of malaria-specific IgG3, and protection against Plasmodium falciparum malaria during infancy: A birth cohort study in Benin.
Dechavanne C; Dechavanne S; Sadissou I; Lokossou AG; Alvarado F; Dambrun M; Moutairou K; Courtin D; Nuel G; Garcia A; Migot-Nabias F; King CL
PLoS Med; 2017 Oct; 14(10):e1002403. PubMed ID: 28991911
[TBL] [Abstract][Full Text] [Related]
19. Qualification of a homogeneous cell-based neonatal Fc receptor (FcRn) binding assay and its application to studies on Fc functionality of IgG-based therapeutics.
Mathur A; Arora T; Liu L; Crouse-Zeineddini J; Mukku V
J Immunol Methods; 2013 Apr; 390(1-2):81-91. PubMed ID: 23384837
[TBL] [Abstract][Full Text] [Related]
20. Research progress on neonatal Fc receptor and its application.
Hu M; Wei S; Zhou W; Wang P
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 50(4):537-544. PubMed ID: 34704415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
